test

Nicholas Boston

@Highvista Strategies Llc

Latest period2024 - Q3ReportedManaged Assets$289.961MTotal holdings142
Assets growth rate5.92%Assets growth rate (2-Q avg)1.78%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Highvista Strategies Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 142 positions.

Assets under management

The assets under management (AUM) of Highvista Strategies Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 289.961M in assets, with a quarterly growth rate of 5.92% and a 2-quarter average growth rate of 1.78%. The portfolio is managed by Nicholas Boston, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
MUMicron Technology Inc
Recent Activity
Exited
0%
$1.171M
8,900 shares@ $131.53 avg price
AMDAdvanced Micro Devices Inc
Recent Activity
Exited
0%
$1.119M
6,900 shares@ $162.21 avg price
TRMLTourmaline Bio Inc
Recent Activity
Exited
0%
$1.072M
83,397 shares@ $12.86 avg price
BILIBilibili Inc
Recent Activity
Exited
0%
$723,472
46,857 shares@ $15.44 avg price
HTHTH World Group Ltd
Recent Activity
Exited
0%
$634,046
19,029 shares@ $33.32 avg price
ASNDAscendis Pharma A S
Recent Activity
Exited
0%
$617,392
4,527 shares@ $136.38 avg price
UTHRUnited Therapeutics Corp Del
Recent Activity
Exited
0%
$448,837
1,409 shares@ $318.56 avg price
SRPTSarepta Therapeutics Inc
Recent Activity
Exited
0%
$373,512
2,364 shares@ $158.0 avg price
EDUNew Oriental Ed & Technology
Recent Activity
Exited
0%
$357,558
4,600 shares@ $77.73 avg price
FDMT4d Molecular Therapeutics In
Recent Activity
Exited
0%
$326,017
15,532 shares@ $21.0 avg price